These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 3867286)

  • 21. Drug eruption due to intravesical instillations of both epirubicin and mitomycin C.
    Okumura A; Oishi N; Kaji K; Imamura T; Fuse H
    J Dermatol; 2009 Jul; 36(7):419-22. PubMed ID: 19583691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of intravesical instillation on performance of uCYT+ test.
    Lodde M; Mian C; Negri G; Vittadello F; Comploj E; Palermo S; Staffler A; Brössner C; Pycha A
    Urology; 2004 May; 63(5):878-81. PubMed ID: 15134970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pathological changes associated with topical chemotherapy of adriamycin for bladder cancer].
    Fujioka T; Ishii N; Chiba R
    Hinyokika Kiyo; 1983 Aug; 29(8):869-73. PubMed ID: 6675437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergistic cytotoxicity and apoptosis by Apo-2 ligand and adriamycin against bladder cancer cells.
    Mizutani Y; Yoshida O; Miki T; Bonavida B
    Clin Cancer Res; 1999 Sep; 5(9):2605-12. PubMed ID: 10499639
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Intravesical chemotherapy with 4'-EPI-adriamycin in patients with superficial bladder tumors (randomized study)].
    Tsushima T; Matsumura Y; Ozaki Y; Akagi T; Obama T; Nasu Y; Ohmori H
    Hinyokika Kiyo; 1985 Dec; 31(12):2215-8. PubMed ID: 3868934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New potential therapy for orthotopic bladder carcinoma by combining HVJ envelope with doxorubicin.
    Kawano H; Komaba S; Yamasaki T; Maeda M; Kimura Y; Maeda A; Kaneda Y
    Cancer Chemother Pharmacol; 2008 May; 61(6):973-8. PubMed ID: 17653716
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Adriamycin and mitomycin dose-dependently downregulate X-kinked inhibitor of apoptosis protein in human bladder cancer cells].
    Yin ZF; Li M; Lai YQ; Yuan YM; Liu G; Chen L; Gan L; Na YQ
    Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(25):1774-7. PubMed ID: 17054846
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravesical epirubicin versus doxorubicin for superficial bladder tumors (stages pTa and pT1): a randomized prospective study.
    Ali-el-Dein B; el-Baz M; Aly AN; Shamaa S; Ashamallah A
    J Urol; 1997 Jul; 158(1):68-73; discussion 73-4. PubMed ID: 9186325
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Postoperative prophylactic intravesical instillation of tetrahydropyranyl-adriamycin (THP) for superficial bladder cancer].
    Kanayama H; Yokota K; Kurokawa Y; Kagawa S; Yokozeki H; Inai T; Ogawa I; Akazawa S; Hashimoto H; Mizuta K
    Gan To Kagaku Ryoho; 1999 Apr; 26(5):651-5. PubMed ID: 10234296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized controlled trial of short-term versus long-term prophylactic intravesical instillation chemotherapy for recurrence after transurethral resection of Ta/T1 transitional cell carcinoma of the bladder.
    Koga H; Kuroiwa K; Yamaguchi A; Osada Y; Tsuneyoshi M; Naito S
    J Urol; 2004 Jan; 171(1):153-7. PubMed ID: 14665865
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Penetration of mitomycin C in human bladder.
    Wientjes MG; Badalament RA; Wang RC; Hassan F; Au JL
    Cancer Res; 1993 Jul; 53(14):3314-20. PubMed ID: 8324743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravesical administration of doxorubicin to swine bladder using magnetically targeted carriers.
    Leakakos T; Ji C; Lawson G; Peterson C; Goodwin S
    Cancer Chemother Pharmacol; 2003 Jun; 51(6):445-50. PubMed ID: 12802508
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized study of single instillation of epirubicin for superficial bladder carcinoma: long-term clinical outcomes.
    Liu B; Wang Z; Chen B; Yu J; Zhang P; Ding Q; Zhang Y
    Cancer Invest; 2006 Mar; 24(2):160-3. PubMed ID: 16537185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paclitaxel and cisplatin as intravesical agents against non-muscle-invasive bladder cancer.
    Hadaschik BA; ter Borg MG; Jackson J; Sowery RD; So AI; Burt HM; Gleave ME
    BJU Int; 2008 Jun; 101(11):1347-55. PubMed ID: 18384637
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Investigation of retention time of intravesical instillation therapy with pirarubicin (THP)].
    Sugano O; Shoji N; Hatakeyama T; Kato H
    Gan To Kagaku Ryoho; 1996 Aug; 23(9):1169-74. PubMed ID: 8751805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravesical instillation of Adriamycin. A model for standardization of the chemotherapy.
    Eksborg S; Nilsson SO; Edsmyr F
    Eur Urol; 1980; 6(4):218-20. PubMed ID: 7389775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antitumor activity of common antibiotics against superficial bladder cancer.
    Kamat AM; Lamm DL
    Urology; 2004 Mar; 63(3):457-60. PubMed ID: 15028437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Characteristic and effective usage of adriamycin].
    Horiuchi K; Akimoto M
    Gan To Kagaku Ryoho; 1996 Dec; 23(14):1916-9. PubMed ID: 8978797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Absorption of epirubicin instilled intravesically immediately after transurethral resection of superficial bladder cancer.
    Tsushima T; Miyaji Y; Noda M; Nasu Y; Kumon H; Ohmori H
    Urol Int; 1998; 60(3):161-4. PubMed ID: 9644786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.